No Cyclophosphamide+Bortezomib+Dexamethasone (NO CVD), Cyclophosphamide+Bortezomib+Dexamethasone (CVD), Phase 3, Newly Diagnosed Multiple Myeloma (NDMM), Alkylating Agents
### Instruction:
Identify the study with the following condition. 
### Input:
No Cyclophosphamide+Bortezomib+Dexamethasone (NO CVD), Cyclophosphamide+Bortezomib+Dexamethasone (CVD), Phase 3, Newly Diagnosed Multiple Myeloma (NDMM), Alkylating Agents 
### Output:
Popular Name is Myeloma XI, Study ID is NCT01554852